Company / Shares Outstanding
Janux Therapeutics, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
62.0M
FY2025
5-year range
23.5M / 62.0M
FY2021-FY2025
Trend
+15.3%
vs FY2024
Sector context
#142 of 212
Health Care
What the data says
At 61966999.00, Janux Therapeutics, Inc.'s shares outstanding ranks #71 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 915146.00 in FY2020 to 61966999.00 in FY2025.
Based on SEC 10-K filings.
61966999.00 in FY2025 with a 5-year CAGR of +132.3%.
Increased from 44016283.00 to 61966999.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +132.3%
- 10-Year CAGR
- -
Sector benchmark
#71 of 212 in Health CareTop 33% of 212This company 62.0M Sector average 306.3M
▼
-79.8% below sector average
Key checks
Key Insights
- Janux Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 15.3% year-over-year.
- Ranks #142 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 62.0M | +15.3% |
| FY2024 | 53.8M | +22.1% |
| FY2023 | 44.0M | +6.1% |
| FY2022 | 41.5M | +76.2% |
| FY2021 | 23.5M | +2471.2% |
| FY2020 | 915.1K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026